9 months ago
SRPT
AnalystsMitchell KapoorMitchell Kapoor's Stock Forecasts
AnalystsMitchell Kapoor
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4999 out of 5014 analysts
Average Return
-7.29%
Win Rate
39%125 out of 320
Risk vs Reward
Poor
Good
Mitchell Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Instil Bio IncTIL | +363.14% | $6.81 | $31.54 | 2023-11-14 - 2024-11-13 | Buy |
Lexeo Therapeutics IncLXEO | +184.62% | $1.82 | $5.18 | 2025-04-08 - 2025-09-12 | Buy |
Verve Therapeutics IncVERV | +169.90% | $4.12 | $11.12 | 2025-04-14 - 2025-06-18 | Buy |
Summit Therapeutics IncSMMT | +157.29% | $10.98 | $28.25 | 2024-08-12 - 2025-08-11 | Buy |
Avalo Therapeutics IncAVTX | +144.94% | $4.35 | $10.66 | 2025-06-02 - 2025-09-12 | Buy |
Mitchell Kapoor Analyst Color
Get additional color on Mitchell Kapoor's coverage of popular stocks
10 months ago
SRPT
a year ago
SMMT
Mitchell Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crispr Therapeutics AgCRSP | 5 | Buy | $80.00 | +42.20% | Maintains | a month ago |
Halozyme Therapeutics IncHALO | 36 | Buy | $75.00 | -2.47% | Maintains | a month ago |
Ionis Pharmaceuticals IncIONS | 5 | Buy | $65.00 | +2.91% | Maintains | a month ago |
Alumis IncALMS | 13 | Buy | $14.00 | +220.37% | Reiterates | 2 months ago |
Korro Bio IncKRRO | 13 | Buy | $100.00 | +225.10% | Reiterates | 2 months ago |
Oruka Therapeutics IncORKA | 6 | Buy | $45.00 | +192.21% | Reiterates | 2 months ago |
Legend Biotech CorpLEGN | 39 | Buy | $75.00 | +126.52% | Reiterates | 2 months ago |
Tyra Biosciences IncTYRA | 20 | Buy | $30.00 | +139.62% | Reiterates | 2 months ago |
Summit Therapeutics IncSMMT | 14 | Buy | $44.00 | +132.31% | Reiterates | 2 months ago |
Sarepta Therapeutics IncSRPT | 14 | Sell | $10.00 | -42.50% | Downgrades | 3 months ago |
Lyell Immunopharma IncLYEL | 13 | Hold | $10.00 | -22.00% | Maintains | 3 months ago |
Verve Therapeutics IncVERV | 7 | Hold | $13.50 | +21.29% | Downgrades | 3 months ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $30.00 | +162.70% | Reiterates | 3 months ago |
Instil Bio IncTIL | 16 | Buy | $125.00 | +418.67% | Reiterates | 3 months ago |
Boundless Bio IncBOLD | 1 | Buy | $5.00 | +334.78% | Initiates Coverage On | 3 months ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $15.00 | +40.78% | Assumes | 3 months ago |
Kyverna Therapeutics IncKYTX | 7 | Buy | $5.00 | +27.55% | Upgrades | 4 months ago |
Cytomx Therapeutics IncCTMX | 3 | Buy | $5.00 | +150.00% | Reiterates | 4 months ago |
Lexeo Therapeutics IncLXEO | 8 | Buy | $15.00 | +189.58% | Maintains | 4 months ago |
Neurogene IncNGNE | 15 | Buy | $45.00 | +136.84% | Maintains | 4 months ago |
Editas Medicine IncEDIT | 1 | Buy | $3.00 | +11.52% | Initiates Coverage On | 5 months ago |
Cartesian Therapeutics IncRNAC | 16 | Buy | $40.00 | +313.22% | Reiterates | 5 months ago |
Metagenomi IncMGX | 9 | Buy | $7.00 | +276.34% | Maintains | 5 months ago |
Zura Bio LtdZURA | 6 | Hold | $3.00 | +50.00% | Maintains | 5 months ago |
Rani Therapeutics Holdings IncRANI | 15 | Buy | $9.00 | +1,700.00% | Reiterates | 5 months ago |
Century Therapeutics IncIPSC | 16 | Buy | $2.00 | +299.20% | Maintains | 5 months ago |
Abeona Therapeutics IncABEO | 2 | Buy | $15.00 | +133.28% | Reiterates | 6 months ago |
Rallybio CorpRLYB | 19 | Buy | $5.00 | +731.95% | Reiterates | 6 months ago |
Tc Biopharm PLCTCBP | 3 | Buy | $48.00 | +9,500.00% | Maintains | 9 months ago |
Carisma Therapeutics IncCARM | 11 | Buy | $5.00 | +1,236.90% | Maintains | 10 months ago |
Onkure Therapeutics IncOKUR | 4 | Hold | $15.00 | N/A | Reiterates | a year ago |
Rain Oncology IncRAIN2 | 2 | Buy | $19.00 | N/A | Maintains | 3 years ago |
Imago Biosciences IncIMGO | 4 | Hold | $36.00 | N/A | Downgrades | 3 years ago |
Aditxt IncADTX | 1 | Buy | $1,600,000.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.